Stock market today: Nifty50 opens below 24,800; BSE Sensex down over 170 points

Analysts anticipate continued positive movement on Friday, driven by supportive monetary policies, good monsoon predictions and increased festive season demand. (AI image) Stock market today: Nifty50 and BSE Sensex, the Indian equity benchmark indices, opened in red on Friday. While Nifty50 was below 24,800, BSE Sensex was down over 170 points. At 9:17 AM, Nifty50…

Read More

S&P Global warns! Taking out Russian oil would turn price dynamics ‘upside down’; Trump tariffs driving India to economic independence

As the world’s third-largest oil supplier, Russia’s position is significant. (AI image) Taking Russian oil out of the global market would turn the price dynamic ‘upside down’, says S&P Global Commodity Insights co-president Dave Ernsberger. Geopolitical factors are expected to continue influencing oil markets in the coming year, with a complex relationship between policies and…

Read More

‘Curb Russia oil imports’: US tells India – Crude buy key factor in reducing tariffs, sealing trade deal

US trade representatives emphasised to their Indian colleagues that addressing the Russian oil issue was essential. (AI image) India-US trade deal is contingent on India curbing its Russian crude oil imports, US trade negotiators have reportedly told Indian officials. Trade officials from the United States have informed India’s negotiators that a curb in Russian oil…

Read More

India-US trade deal: Commerce Ministry shares update on Piyush Goyal’s visit; says aim to ‘achieve early conclusion’

A delegation headed by Piyush Goyal conducted an official visit to the US from September 22-24, 2025. (AI image) India-US trade deal talks: India and the US have decided to continue working towards an early conclusion to the trade agreement, according to a statement by the Ministry of Commerce & Industry.Sharing an update on Commerce…

Read More

Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in

For Indian pharmaceutical exports, the US represents the primary market, comprising about 35% of total exports, with a value reaching about $10 billion in FY25. (AI image) US President Donald Trump’s move to impose 100% tariffs on branded and patented pharmaceutical exports has rattled Indian pharma stocks, even though most companies earn from US markets…

Read More

Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on D-Street

Several prominent Indian pharmaceutical firms, including Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, and Zydus Lifesciences, maintain substantial export operations to the USA. (AI image) Pharma stocks hit by Trump’s tariffs: Pharmaceutical stocks declined sharply by up to 5% on Friday, September 26, following US President Donald Trump’s declaration of imposing 100% tariffs…

Read More

‘Severe sectoral pain’: India’s exports to US fall for third straight month as Trump imposes 50% tariffs; what should be the policy response?

About one-third of Indian exports to the US face no tariffs, indicating that the actual impact on tariff-affected goods is significantly higher. (AI image) India’s exports to the US have fallen for the third straight month in August as Donald Trump administration’s 50% tariffs came into effect. According to Global Trade and Research Initiative founder…

Read More